Epilepsy: all 1,842 studies

Page 6 of 19. Open to participants first (423), then studies with results posted, then the rest; newest registration first within each.

• Transcranial Magnetic Stimulation for EpilepsyTerminatedNCT02757547Not applicableResults posted
• fMRI Guided TMS Enhancement of Associative Memory NetworksTerminatedNCT02749422Not applicableResults posted
• Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)CompletedNCT02741193Not applicableResults posted
• Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary GeneralizationCompletedNCT02726074Phase 4Results posted
• Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy SubjectsCompletedNCT02724423Phase 1Results posted
• Repeat Dose Safety Study of NRL-1 in Epilepsy SubjectsCompletedNCT02721069Phase 3Results posted
• Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.CompletedNCT02710890Phase 2/3Results posted
• Characterization of Epilepsy Patients BEEP 2bCompletedNCT02707965Phase 1Results posted
• IVIG in Patients With VGKC Ab Associated Autoimmune EpilepsyTerminatedNCT02697292Phase 3Results posted
• Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset SeizuresCompletedNCT02687711Results posted
• A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromeCompletedNCT02682927Phase 3Results posted
• An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyTerminatedNCT02625090Phase 2Results posted
• A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994CompletedNCT02582866Phase 3Results posted
• A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02565108Phase 2Results posted
• An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02564952Phase 2Results posted
• PF-06372865 in Subjects With Photosensitive EpilepsyCompletedNCT02564029Phase 2Results posted
• TAK-935 Multiple Rising Dose Study in Healthy ParticipantsCompletedNCT02539134Phase 1Results posted
• Transcranial Electrical Neuromodulation for Suppressing Epileptiform DischargesTerminatedNCT02516228Not applicableResults posted
• A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935CompletedNCT02497235Phase 1Results posted
• A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyCompletedNCT02495844Phase 2Results posted
• Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)CompletedNCT02491073Results posted
• Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset SeizuresCompletedNCT02477839Phase 3Results posted
• Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)TerminatedNCT02474407Phase 2Results posted
• An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy SubjectsCompletedNCT02427607Phase 3Results posted
• Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic SeizuresCompletedNCT02408549Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic MedicationsCompletedNCT02408523Phase 3Results posted
• BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic PatientsCompletedNCT02404168Phase 4Results posted
• Low Frequency Electrical Stimulation of the Fornix in Intractable Mesial Temporal Lobe Epilepsy (MTLE)CompletedNCT02383407Not applicableResults posted
• Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System UsersCompletedNCT02362373Phase 4Results posted
• Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic EpilepsiesCompletedNCT02358538Phase 2Results posted
• Staccato Alprazolam and Photoparoxysmal ResponseCompletedNCT02351115Phase 2Results posted
• Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure DisordersCompletedNCT02324673Phase 1/2Results posted
• Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure DisorderCompletedNCT02318602Phase 3Results posted
• An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.TerminatedNCT02316847Phase 2Results posted
• Dosage Form Proportionality of Opicapone To-Be-Marketed FormulationCompletedNCT02305329Phase 1Results posted
• Food Effect and Dosage Form Proportionality Study of Eslicarbazepine AcetateCompletedNCT02288312Phase 1Results posted
• The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of WarfarinCompletedNCT02287415Phase 1Results posted
• Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine AcetateCompletedNCT02284880Phase 1Results posted
• Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and CarbamazepineCompletedNCT02284854Phase 1Results posted
• Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor FunctionCompletedNCT02284828Phase 1Results posted
• Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed FormulationCompletedNCT02283840Phase 1Results posted
• Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.CompletedNCT02283827Phase 1Results posted
• A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and TopiramateCompletedNCT02283814Phase 1Results posted
• Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac RepolarizationCompletedNCT02283788Phase 1Results posted
• Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepineCompletedNCT02281591Phase 1Results posted
• An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093CompletedNCT02281526Phase 1Results posted
• Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.CompletedNCT02281448Phase 1Results posted
• An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093CompletedNCT02281422Phase 1Results posted
• Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093CompletedNCT02279667Phase 1Results posted
• Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain TumorsCompletedNCT02276053Results posted
• A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.CompletedNCT02229318Not applicableResults posted
• GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet SyndromeCompletedNCT02224703Phase 3Results posted
• A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsCompletedNCT02224690Phase 3Results posted
• A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With EpilepsyCompletedNCT02201251Phase 3Results posted
• Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset SeizuresCompletedNCT02192814Phase 3Results posted
• Methylphenidate Treatment of Attention Deficits in EpilepsyCompletedNCT02178995Phase 4Results posted
• Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its MetabolitesCompletedNCT02172755Phase 1Results posted
• The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of DigoxinCompletedNCT02172742Phase 1Results posted
• A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093CompletedNCT02171234Phase 1Results posted
• A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093CompletedNCT02171195Phase 1Results posted
• The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093CompletedNCT02170649Phase 1Results posted
• A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093CompletedNCT02170077Phase 2Results posted
• Pharmacokinetics, Efficacy and Tolerability of BIA 2-093CompletedNCT02170064Phase 2Results posted
• A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure ClustersTerminatedNCT02161185Phase 3Results posted
• A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset SeizuresCompletedNCT02124564Phase 3Results posted
• Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label StudyCompletedNCT02100644Phase 4Results posted
• Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative FlavoursCompletedNCT02021461Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMUCompletedNCT01999777Phase 3Results posted
• Lamotrigine BioequivalenceCompletedNCT01995825Phase 4Results posted
• Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)CompletedNCT01992393Not applicableResults posted
• A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.CompletedNCT01969851Phase 2Results posted
• A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset SeizuresCompletedNCT01964560Phase 3Results posted
• Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset SeizuresCompletedNCT01954121Phase 3Results posted
• Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset SeizuresCompletedNCT01921205Phase 3Results posted
• Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With EpilepsyTerminatedNCT01910129Not applicableResults posted
• Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)TerminatedNCT01891890Phase 3Results posted
• A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy VolunteersCompletedNCT01879345Phase 1Results posted
• A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy VolunteersCompletedNCT01879332Phase 1Results posted
• VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)CompletedNCT01846741Not applicableResults posted
• Lactic Acidosis During and After SeizuresCompletedNCT01833247Results posted
• Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset SeizuresCompletedNCT01832038Phase 3Results posted
• A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset SeizuresCompletedNCT01777139Phase 3Results posted
• Arterial Spin Labeling MRI Focal Abnormalities in Refractory EpilepsyCompletedNCT01772654Not applicableResults posted
• Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)CompletedNCT01745952Not applicableResults posted
• Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With EpilepsyCompletedNCT01728077Phase 3Results posted
• A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset SeizuresCompletedNCT01710657Phase 3Results posted
• A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With EpilepsyCompletedNCT01689649Phase 4Results posted
• An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With EpilepsyCompletedNCT01682681Results posted
• Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy VolunteersCompletedNCT01679002Phase 1Results posted
• Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy VolunteersCompletedNCT01678976Phase 1Results posted
• Allopregnanolone for the Treatment of Traumatic Brain InjuryCompletedNCT01673828Phase 2Results posted
• Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination TherapyCompletedNCT01673282Results posted
• Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGSTerminatedNCT01668654Phase 3Results posted
• Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)CompletedNCT01653262Phase 3Results posted
• Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset SeizuresTerminatedNCT01648101Phase 3Results posted
• First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical PatientsCompletedNCT01627860Phase 4Results posted
• Medication Adherence in Individuals With EpilepsyCompletedNCT01566500Results posted
• IVIG Treatment for Refractory Immune-Related Adult EpilepsyTerminatedNCT01545518Phase 2Results posted
• Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure ClustersTerminatedNCT01529034Phase 3Results posted
• Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset SeizuresCompletedNCT01527513Phase 2Results posted

← Epilepsy overview